法国儿童急性缺血性卒中的再通治疗
KidClot多中心全国性回顾性队列纳入2015年1月1日至2018年5月31日法国30个中心68例接受再通治疗的儿童急性缺血性卒中患者(排除新生儿),其中静脉溶栓44例、血管内治疗40例。血管内治疗组入院pedNIHSS更高(16 vs 9,P<.01)、发病至影像时间更长(3小时7分 vs 2小时39分,P=0.04)。血管内治疗组术后成功再灌注(≥mTICI 2b)率为80.0%(32/40),死亡3例(4.4%),症状性颅内出血1例且全部颅内出血4例均发生于血管内治疗组。90天mRS中位数2分、1年1分,EVT与单纯IVT组间无显著差异,尽管初始严重程度不同。作者认为儿童AIS使用EVT和/或IVT是安全的。
要点
- 68例儿童AIS再通治疗(IVT 44例、EVT 40例),30个中心,中位年龄11岁,前循环受累57例(83.8%)。
- EVT组入院pedNIHSS中位16分高于单纯IVT组9分(P<.01),发病至影像时间EVT组3小时7分 vs 单纯IVT组2小时39分(P=0.04)。
- EVT组术后成功再灌注(≥mTICI 2b)率80.0%(32/40),死亡3例(4.4%)。
- 颅内出血4例、症状性颅内出血1例,均发生于EVT组;局灶性脑动脉病持续近端动脉狭窄更常见(P<.01)。
- 90天mRS中位2分、1年1分,EVT与单纯IVT组间无显著差异,尽管初始严重程度不同;作者认为儿童AIS使用EVT和/或IVT是安全的。
适用人群与场景
- 儿童(排除新生儿)急性缺血性卒中并接受再通治疗者,数据来自法国30个中心,2015年1月1日至2018年5月31日。
- 共68例:静脉溶栓44例、血管内治疗40例;男孩44例(64.7%);中位年龄11岁(IQR 4-16岁);前循环受累57例(83.8%)。
诊断标准与关键阈值
- 主要终点为90天良好功能结局,定义为改良Rankin量表(mRS)0-2分(0分无症状,6分死亡)。
- pedNIHSS评分:0分无症状,1-4分为轻微卒中,5-15分为轻度卒中,>15-20分为重度卒中。
- 成人ASPECTS评分:初始10分,每累及一个区域扣1分(10分为无病灶,0分为最大病灶)。
处置流程与药物剂量
- 再通策略为静脉溶栓和/或血管内治疗;静脉溶栓组发病至溶栓中位时间3小时30分钟(IQR 2小时33分钟至4小时28分钟)。
- 血管内治疗组术后成功再灌注定义为≥改良脑梗死溶栓(mTICI)2b级,发生率为80.0%(32/40)。
红旗征与不能漏的情况
- 颅内出血4例、症状性颅内出血1例,均发生于血管内治疗组。
- 死亡3例(4.4%)。
研究设计与关键结果
- KidClot多中心全国性回顾性队列,纳入30个中心68例儿童AIS再通治疗患者:IVT 44例、EVT 40例;男孩44例(64.7%);中位年龄11岁(IQR 4-16岁);前循环受累57例(83.8%)。
- 入院pedNIHSS中位13分(IQR 7-19),EVT组16分(IQR 10-20)高于单纯IVT组9分(IQR 6-17)(P<.01)。
- 发病至影像中位时间EVT组3小时7分钟(IQR 2小时3分钟至6小时24分钟)长于单纯IVT组2小时39分钟(IQR 1小时51分钟至4小时13分钟)(P=0.04)。
- 入院ASPECTS中位8分(IQR 6-9);主要病因心源性栓塞21例(30.9%)、局灶性脑动脉病17例(25.0%)。
- EVT组术后成功再灌注(≥mTICI 2b)率80.0%(32/40);局灶性脑动脉病中持续近端动脉狭窄更常见(P<.01)。
- 死亡3例(4.4%);24小时pedNIHSS中位降低4分(IQR 0-9)。
- 颅内出血4例、症状性颅内出血1例,均发生于EVT组。
- 90天mRS中位2分(IQR 0-3)、1年mRS中位1分(IQR 0-2),EVT与单纯IVT组间无显著差异,尽管初始严重程度不同。
证据类型、等级与局限
- 证据类型:多中心全国性回顾性队列研究(KidClot)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,儿童AIS使用EVT和/或IVT是安全的;该结论来自回顾性队列,EVT组初始pedNIHSS更高且发病至影像时间更长,组间功能结局无显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There is to date limited evidence that revascularization strategies are associated with improved functional outcome in children with acute ischemic stroke (AIS).
OBJECTIVES: To report clinical outcomes and provide estimates of revascularization strategy safety and efficacy profiles of intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) in children with AIS.
DESIGN, SETTING, AND PARTICIPANTS: The KidClot multicenter nationwide cohort study retrospectively collected data of children (neonates excluded) with AIS and recanalization treatment between January 1, 2015, and May 31, 2018. Data analysis was performed from January 1, 2015, to May 31, 2019.
EXPOSURE: IVT and/or EVT.
MAIN OUTCOMES AND MEASURES: Primary outcome was day 90 favorable outcome (modified Rankin Scale [mRs] 0-2, with 0 indicating no symptoms and 6 indicating death). Secondary end points included 1-year favorable outcome (mRs, 0-2), mortality, and symptomatic intracerebral hemorrhage. Other measures included the Pediatric National Institutes of Health Stroke Scale (pedNIHSS), with pedNIHSS 0 indicating no symptoms, 1 to 4 corresponding to a minor stroke, 5 to 15 corresponding to a mild stroke, greater than 15 to 20: severe stroke, and the adult Alberta Stroke Program Early CT Score (ASPECTS), which provides segmental assessment of the vascular territory, with 1 point deducted from the initial score of 10 for every region involved (from 10 [no lesion] to 0 [maximum lesions]).
RESULTS: Overall, 68 children were included in 30 centers (IVT [n = 44]; EVT [n = 40]; 44 boys [64.7%]; median [IQR] age, 11 [4-16] years; anterior circulation involvement, 57 [83.8%]). Median (IQR) pedNIHSS score at admission was 13 (7-19), higher in the EVT group at 16 (IQR, 10-20) vs 9 (6-17) in the IVT only group (P < .01). Median time from stroke onset to imaging was higher in the EVT group at 3 hours and 7 minutes (IQR, 2 hours and 3 minutes to 6 hours and 24 minutes) vs 2 hours and 39 minutes (IQR, 1 hour and 51 minutes to 4 hours and 13 minutes) (P = .04). Median admission ASPECTS score was 8 (IQR, 6-9). The main stroke etiologies were cardioembolic (21 [30.9%]) and focal cerebral arteriopathy (17 [25.0%]). Median (IQR) time from stroke onset to IVT was 3 hours and 30 minutes (IQR, 2 hours and 33 minutes to 4 hours and 28 minutes). In the EVT group, the rate of postprocedure successful reperfusion (≥modified Treatment in Cerebral Infarction 2b) was 80.0% (32 of 40). Persistent proximal arterial stenosis was more frequent in focal cerebral arteriopathy (P < .01). Death occurred in 3 patients (4.4%). Median pedNIHSS reduction at 24 hours was 4 (IQR, 0-9) points. Intracerebral hemorrhage occurred in 4 patients and symptomatic intracerebral hemorrhage occurred in 1 patient, all in the EVT group. The median mRS was 2 (IQR, 0-3) at day 90 and 1 (IQR, 0-2) at 1 year, which was not significantly different between EVT and IVT only groups, although different in initial severity.
CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that use of EVT and/or IVT is safe in children with AIS.
参考来源
- Kossorotoff M, Kerleroux B, Boulouis G, et al. Recanalization Treatments for Pediatric Acute Ischemic Stroke in France. JAMA Netw Open. 2022. PMID: 36107427. doi:10.1001/jamanetworkopen.2022.31343
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。